We use cookies to understand how visitors search for and consume the information we provide, so that we can improve their experience. By browsing this website, you indicate your acceptance of the use of such cookiesAcceptRead more
April 9, 2013: GenSight Biologics Raises €32m in a Series A Financing for Ophthalmic GeneTherapy.
Events & presentations
GenSight Biologics Raises €32m in a Series A Financing for Ophthalmic GeneTherapy. Learn more